leftspacer middlespacer rightspacer
Media Menu
Featured Material

MAPS Bulletin Summer 2014: Research Edition
Research > MDMA
May 13, 2012

U.S. Veterans Study: Subject Drops Out Following Single Successful Treatment

On May 13, 2012, the third subject completed their long-term follow-up evaluations in our ongoing study in U.S. veterans, firefighters, or police officers with chronic, treatment-resistant PTSD. This subject was a veteran suffering from chronic, treatment-resistant PTSD as a result of military service, who after one MDMA-assisted psychotherapy session felt so improved that he needed no further treatments with MDMA or any other drug. He agreed, however, to return for the 12-month follow-up interview to evaluate his PTSD symptoms. According to lead clinical investigator Michael Mithoefer, M.D., this subject experienced sustained benefits with scores on the CAPS at the 12-month follow-up below the cutoff for participation in the study.

Back to MDMA-Assisted Psychotherapy Research

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.